Clinical Trials · NCT01621178
A Study Comparing Dulaglutide With Insulin Glargine on Glycemic Control in Participants With Type 2 Diabetes (T2D) and Moderate or Severe Chronic Kidney Disease (CKD)
- Phase
- Phase 3
- Recruitment status
- Completed
- Sponsor
- Eli Lilly and Company
- Enrollment
- 577
- Start date
- Jul 2012
- Locations
- 89 sites, 9 countries
- Primary endpoint
- Change From Baseline in Hemoglobin A1c (HbA1c)